ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,252Medicare Part D Prescriptions Filled, Including Refills

Rank: 657 out of 6645

$2.96M Total Retail Price of All Prescriptions

Rank: 38 out of 6645

344 Patients Receiving at Least One Drug in Part D
31%Patients 65 Years and Older
80% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 344 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

38% of this provider’s 344 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 3,027 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

39% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$263 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
HYDROCODONE-ACETAMINOPHEN 517 108 S3 1 5
NORVIR 345 88 2 133
TRUVADA 297 51 3 135
LISINOPRIL 289 132 4 3
ACYCLOVIR 281 62 5 206
GABAPENTIN 253 60 6 18
EPZICOM 244 45 7 223
OMEPRAZOLE 230 97 8 6
REYATAZ 185 55 9 197
PREZISTA 176 12 10 194
ATORVASTATIN CALCIUM 175 65 11 10
SIMVASTATIN 172 88 12 1
ANDROGEL 163 32 S3 13 279
TRAZODONE HCL 151 44 14 60
ISENTRESS 150 0 15 173
PRAVASTATIN SODIUM 144 17 16 20
METFORMIN HCL 142 74 17 7
LEVOTHYROXINE SODIUM 141 48 18 4
ZOLPIDEM TARTRATE 140 11 19 17
CYMBALTA 136 27 20 78
VIREAD 127 0 21 259
OXYCODONE HCL 126 13 S2 22 162
ATRIPLA 121 27 23 254
SULFAMETHOXAZOLE-TRIMETHOPRIM 114 42 24 134
TRAMADOL HCL 111 31 25 30
VALACYCLOVIR 109 16 26 271
METOPROLOL TARTRATE 106 62 27 13
VIRAMUNE XR 105 26 28 371
TAMSULOSIN HCL 100 25 29 22
FUROSEMIDE 95 46 30 11
TESTOSTERONE CYPIONATE 95 19 S3 30 324
MIRTAZAPINE 93 17 32 70
CARISOPRODOL 89 0 R 33 94
BACLOFEN 87 0 34 100
PROAIR HFA 86 16 35 32
LYRICA 81 33 36 127
GLIPIZIDE 77 40 37 23
BUPROPION XL 77 0 37 225
AMLODIPINE BESYLATE 76 33 39 2
LOVAZA 75 0 40 68
GEMFIBROZIL 75 0 40 96
ABILIFY 75 12 40 204
SUSTIVA 74 40 43 413
KALETRA 71 0 44 360
SPIRONOLACTONE 70 36 45 85
IBUPROFEN 70 0 45 42
PAROXETINE HCL 69 20 47 72
INTELENCE 68 0 48 305
LEXIVA 68 37 48 511
BENAZEPRIL HCL 68 19 48 21
ATENOLOL 65 22 51 8
LOVASTATIN 64 15 52 15
CRESTOR 63 20 53 34
SERTRALINE HCL 62 40 54 43
DRONABINOL 60 0 55 463
FLUCONAZOLE 60 15 55 298
INSULIN SYRINGE 58 0 57 61
AZITHROMYCIN 57 0 58 44
DIPHENOXYLATE-ATROPINE 57 0 58 214
QUETIAPINE FUMARATE 57 0 58 101
HYDROCHLOROTHIAZIDE 56 31 61 9
CARVEDILOL 56 26 61 25
CITALOPRAM HBR 54 0 63 35
FENOFIBRATE 50 0 64 74
MORPHINE SULFATE ER 50 0 S2 64 124
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 4, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.